Skip to content

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

Home
About Us
Office
E-Library
Research Support
Blog
Donation
Contact Us

March 26, 2025

New Releases from NCBI BookshelfEffectiveness of Post-Discharge Contacts on Health Care Utilization and Patient Satisfaction.Effectiveness of Post-Discharge Contacts on Health Care Utilization and Patient Satisfaction.

Leave a Comment / Uncategorized / admin

The Veterans Health Administration (VHA) is the largest integrated health system in the nation. Veterans seeking care through the VHA […]

New Releases from NCBI BookshelfAxicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma.Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfCiltacabtagene autoleucel for treating relapsed or refractory multiple myeloma (terminated appraisal).Ciltacabtagene autoleucel for treating relapsed or refractory multiple myeloma (terminated appraisal).

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfMosunetuzumab for treating relapsed or refractory follicular lymphoma.Mosunetuzumab for treating relapsed or refractory follicular lymphoma.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfDifelikefalin for treating pruritus in people having haemodialysis.Difelikefalin for treating pruritus in people having haemodialysis.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfOlaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer.Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfOlaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy.Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfBrexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and over.Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and over.

Leave a Comment / Uncategorized / admin

Post Content

New Releases from NCBI BookshelfDeveloping research collaborations and building capacity in palliative and end-of-life care in the North West Coast of England: the PalCaRe-NWC partnership [Internet].Developing research collaborations and building capacity in palliative and end-of-life care in the North West Coast of England: the PalCaRe-NWC partnership [Internet].

Leave a Comment / Uncategorized / admin

The North West Coast area of England (Lancashire, Merseyside, Cheshire and South Cumbria) has high palliative care need (third highest

New Releases from NCBI BookshelfIbrutinib with venetoclax for untreated chronic lymphocytic leukaemia.Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia.

Leave a Comment / Uncategorized / admin

Post Content

Useful Links

NEWREDMARS SKILL AND RESEARCH FOUNDATION

Registration No: 771800548 Contact Number : +91-8249516996

Publication
Skill Development
Blog Writing

Research
Awareness Camp
Digital Research

Ngo Darpan
Service
Donation

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Term and Condition
Privacy Policy
Disclaimer

Scroll to Top